Research Disclaimer: All compounds described are sold exclusively for in-vitro and laboratory research use. Not for unsupervised use. This content does not constitute medical advice.
When a peptide COA reports "Purity: 98.7% (HPLC, area%)", what does that actually mean? Understanding the measurement methodology is critical for evaluating whether a compound meets research standards — and for understanding what the remaining 1.3% might be.
What HPLC Area% Means#
The measurement:
HPLC (High-Performance Liquid Chromatography) separates compounds by their differential affinity for a stationary phase. As each compound elutes from the column, a UV detector measures its absorbance at a fixed wavelength (typically 214 nm or 220 nm for peptides).
Area% calculation:
- The detector produces a chromatogram: peaks corresponding to different compounds
- Area under each peak is integrated
- Purity (area%) = (area of target peak) / (total area of all peaks) × 100%
What this means in practice:
- 98.7% purity = the target peptide accounts for 98.7% of all UV-absorbing material detected
- The remaining 1.3% = other UV-absorbing compounds present (impurities, byproducts, degradants)
Important limitation: HPLC area% measures UV absorption, not molar concentration. Compounds with different extinction coefficients (different numbers of aromatic amino acids, different chromophores) absorb UV differently. This is why area% is an approximation, not an absolute mass purity measurement.
What Are the Impurities?#
In research peptides, impurities typically come from:
-
Synthesis byproducts: Failed sequences (n-1, n-2 peptides — peptides missing one or more amino acids from the target sequence); incorrectly assembled sequences; racemized amino acids; protecting group remnants from Fmoc-SPPS synthesis
-
Degradation products: Oxidized residues (most commonly Met and Trp oxidation; Asn/Asp deamidation); hydrolysis at Asp-Pro bonds
-
Aggregates: Self-associated peptide multimers that elute differently from monomers
-
Residual synthesis reagents: HATU, HOBt, DIC, TFA salts — most removed during purification but trace amounts may remain
Research impact of impurities:
- Structural analogs (n-1 sequences) may have partial receptor affinity → confound dose-response data
- Oxidized forms: reduced biological activity → appear to reduce EC50 if significant proportion
- Endotoxin (separate from HPLC purity): potent pro-inflammatory agent at pg/mL concentrations → critical separate test for in vivo studies
Purity Standards: What Counts as Research Grade?#
| Purity level | Use case |
|---|---|
| ≥95% | Minimum acceptable for in vitro screening |
| ≥98% | Standard for most research peptides; adequate for in vivo rodent studies |
| ≥99% | Preferred for dose-response studies, receptor pharmacology, structural research |
| ≥99.5% | Pharmaceutical API standard; rarely required for preclinical research |
Why 98% is the common research threshold: At ≥98% purity, the maximum impurity contribution is 2% — low enough that in most biological assays, the impurities don't generate detectable pharmacological signal. At 95%, the 5% impurity fraction can contain enough structural analogs to shift EC50 measurements.
Why Purity Alone Is Not Enough: The MS Identity Requirement#
The critical limitation of purity-only testing:
An HPLC purity result of 99.5% tells you that whatever compound is in the vial is very pure. It does NOT tell you that the compound is what you ordered.
A hypothetical scenario: a 15-amino acid peptide with a different sequence than BPC-157 could show 99.5% HPLC purity — but it would not be BPC-157.
Mass spectrometry confirms identity:
- ESI-MS: measures the molecular mass of the compound
- [M+2H]2+ ion for BPC-157 should appear at m/z ~710.8 ± 0.5 Da
- If the measured m/z matches the expected value for BPC-157, the compound is confirmed
- If it doesn't match → the compound may have wrong sequence, missing residues, or wrong modifications
Bottom line: Always require both HPLC purity AND MS identity on the same COA — neither alone is sufficient for research-grade verification.
Semaglutide, €43 · 99.0% purityResearch Use Only. JuicedPharma does not provide medical advice.
Published by JuicedPharma Research Team · October 2026 · Category: Research Protocols & Science
